Schedule 13G ownership disclosure
Immunic Inc
Common Stock, $0.0001 par value · CUSIP: 4525EP101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 10,378,406.00 · Class: 8.22%
- Wilmot B. Harkey
Shares: 10,378,406.00 · Class: 8.22%
- Daniel Mack
Shares: 10,378,406.00 · Class: 8.22%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-015336
- Form type
- SCHEDULE 13G/A
- Filer
- IMMUNIC, INC.
- CIK
- CIK 1280776
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership